Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.
about
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseaseImplications of protein structure instability: from physiological to pathological secondary structure.The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluationDevelopment of a new DNA vaccine for Alzheimer disease targeting a wide range of aβ species and amyloidogenic peptidesBlocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide poolTarget- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersIntranasal Delivery of miR-146a Mimics Delayed Seizure Onset in the Lithium-Pilocarpine Mouse Model.Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Murine models of Alzheimer's disease and their use in developing immunotherapies.Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the futureImmunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles.Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90).Recent advances in the development of immunotherapies for tauopathies
P2860
Q28251394-7D2F0D9F-E85F-472F-BAE9-0617E2401C41Q30416896-1CBA8CCB-17E9-4641-98C4-3258C79E32A0Q30668465-E89F2230-6D34-4FC4-88EA-D1DD43533C71Q34003837-E0EC3EB7-4B81-4F28-88AC-BB7C3092850BQ35005432-B484538A-C39A-4AFF-97B2-A0FF2BD1290DQ35095392-92AC8F8F-F154-4B2F-B9ED-96BA6AB2C5C8Q36347659-EF47E7F0-D920-43D4-85B6-6F1B0BE22F52Q36799584-A2565308-2470-4B9D-BDDC-BDD57B4F1EE0Q37627568-82682470-8669-448D-8464-FBFCEAE6DBC7Q37655247-AC29C8A8-180F-4964-AA3F-79F77D56C35EQ37752915-D02A58C5-AE6B-4D52-859E-3ACD982DC993Q38161675-EC71D4F1-53A4-42F4-90C9-57190375E5A7Q38912261-65F8838B-2262-45DD-B279-8CEDE601B489Q40335819-9E34B9C8-1108-4A62-915B-FE3612DD7290Q42008541-60CE40F1-BA36-417B-88AB-B5414033577FQ42408195-9D7206C7-4B5F-4ED9-8052-5C6923DECD07Q42778736-A029BC0A-D126-499E-96AB-DAD933565FF3
P2860
Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@ast
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@en
type
label
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@ast
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@en
prefLabel
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@ast
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@en
P2860
P921
P1433
P1476
Preventing beta-amyloid fibril ...... ological chaperone inhibitors.
@en
P2093
Martin Sadowski
P2860
P2888
P356
10.1186/1471-2202-9-S2-S5
P478
P5008
P577
2008-12-03T00:00:00Z
P6179
1011295580